US FDA Sending AZ, Other Cancer Sponsors Trial Design Message With Imfinzi AdComm

 
• By Sarah Karlin-Smith
  
red bullhorn with sign underneath that says "attention please"
The FDA's 25 July ODAC meeting appears important for many sponsors developing immunotherapies. • Source: Shutterstock
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers